← 홈

Antibody

1,830개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-12 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,830개
AntibodystaleTae Won KimPhase 2

durvalumab (Imfinzi, CKD-516 plus Durvalumab)

Colorectal Cancer; Solid Tumor · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleFamewave Ltd.Phase 2

nivolumab (Opdivo, CM-24 and Nivolumab - Dose Escalation)

Solid Tumor; Non Small Cell Lung Cancer · Solid Tumor

#SolidTumor#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleFamewave Ltd.Phase 2

nivolumab (Opdivo, CM-24, Nivolumab, Nab paclitaxel and Gemcitabine - Expansion)

Solid Tumor; Non Small Cell Lung Cancer · Solid Tumor

#SolidTumor#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleFamewave Ltd.Phase 2

nivolumab (Opdivo, CM-24, Nivolumab, and Nal-IRI/5-FU/LV - Expansion)

Solid Tumor; Non Small Cell Lung Cancer · Solid Tumor

#SolidTumor#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleInstitute of Hematology & Blood…Phase 2

CM336 Plus Isatuximab (CM336 Plus Isatuximab)

Multiple Myeloma (MM); Multiple Myeloma Light Chain Induced Renal Insufficiency · Multiple Myeloma (MM)

#MultipleMyelomaMM#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleTaizhou Mabtech Pharmaceutical …Phase 3

CMAB007 (CMAB007)

Chronic Spontaneous Urticaria · Chronic Spontaneous Urticaria

#ChronicSpontaneousUrticaria#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleShanghai Biomabs Pharmaceutical…Phase 3

CMAB008 (CMAB008)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleTaizhou Mabtech Pharmaceutical …Phase 3

CMAB009 (CMAB009)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleTaizhou Mabtech Pharmaceutical …Phase 3

CMAB015 (CMAB015)

Psoriasis · Psoriasis

#Psoriasis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleTaizhou Mabtech Pharmaceutical …Phase 1

CMAB819 (CMAB819)

Squamous Cell Carcinoma of the Head and Neck · Squamous Cell Carcinoma of the Head and

#SquamousCellCarcinomaoftheHeadan#Antibody#Phase1#항체#면역항체+2
효능 ORR 25%임상시험 1상태 DISCONTINUED
AntibodystaleBiogenPhase 1

trastuzumab (Herceptin, CNF2024 + trastuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleCompugen LtdPhase 1

nivolumab (Opdivo, COM701 with Opdivo, COM701 with Opdivo (Nivolumab).)

Advanced Cancer; Ovarian Cancer · Advanced Cancer

#AdvancedCancer#Antibody#Phase1#항체#면역항체+3
효능 ORR 6%임상시험 1상태 ACTIVE
AntibodystaleCorvus Pharmaceuticals, Inc.Phase 1

pembrolizumab (Keytruda, CPI-006 + pembrolizumab)

Non-Small Cell Lung Cancer; Renal Cell Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 3

Daratumumab (CT-P44, CT-P44(Daratumumab))

Refractory or Relapsed Multiple Myeloma · FRα

#FR#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleJanssenApproved

CYCLOSPORINE VS INFLIXIMAB (CYCLOSPORINE VS INFLIXIMAB)

Ulcerative Colitis; Steroid Refractory · FRα

#FR#Antibody#Approved#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleBristol-Myers SquibbPhase 2

Cabiralizumab (Cabiralizumab)

Advanced Pancreatic Cancer · Triple Negative Breast Cancer

#TripleNegativeBreastCancer#Antibody#Phase2#항체#면역항체+3
효능 ORR 20%임상시험 1상태 ACTIVE
AntibodystaleUniversity of ArizonaPhase 2

atezolizumab (Tecentriq, Cabozantinib + Atezolizumab)

Pancreatic Cancer; Metastatic Pancreatic Cancer · Pancreatic Cancer

#PancreaticCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleCaigang LiuPhase 3

Cadonilimab (AK104, Cadonilimab, Cadonilimab (AK104) combined with chemotherapy and bevacizumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleShen FengPhase 2

Cadonilimab+Gem/Cis (Cadonilimab+Gem/Cis)

Intrahepatic Cholangiocarcinoma · Intrahepatic Cholangiocarcinoma

#IntrahepaticCholangiocarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleShanghai Zhongshan HospitalPhase 2

Cadonilimab+Lenvatinib (Cadonilimab+Lenvatinib)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED

32 / 92 페이지

← 이전다음 →